SPECIAL/SUBGROUP / Gilead Sciences / OTHER SPECIAL/SUBGROUP / Best Pharmaceuticals / /
Continent
North America / Europe / /
Country
Poland / United States / /
Event
FDA Phase / Person Communication and Meetings / /
IndustryTerm
treatment of HIV / treatment of HBV / HBV treatment / /
MedicalCondition
HIV infection / HBV infection / HIV / disease / HBV / hepatitis B / virus infection / infection / chronic hepatitis B / /
MedicalTreatment
Blood transfusion / /
Organization
U.S. Department of Health and Human Services / Translational Sciences Office / Data Monitoring Committee / FDA / Division of Anti-viral Products / Food and Drug Administration Center for Drug Evaluation / Priority Biometrics Division / Research Office / Division of Reproductive and Urologic Products / Medical Division / /
Person
Prabha Viswanathan / Stephen Voss / Max Strata / Greg Soon / Joy Mele / Linda Lewis / / /
N21-356s042 Statistical PREA